We are dedicated to pioneering ways to leverage the power of oral enzymes with our novel biologic platform to treat metabolic disorders and beyond. As a mission-driven organization, we are committed to developing novel treatments for people who have—until now—endured without any therapeutic options.

Our first-of-its-kind oral enzyme platform has the power to treat patients with severe and underserved metabolic disorders by breaking down harmful substances in the gastrointestinal (GI) tract, such as oxalate and urate. With our targeted approach, our therapeutics have the potential to reduce the elevated levels of harmful metabolites before they result in severe, debilitating consequences including kidney stones, gout, chronic kidney disease, and end-stage kidney disease.

As an agile and solutions-oriented organization, every decision we make is driven by data and consensus. Improving the lives of patients is the motivation for what we do; passion for innovation drives how we do it.